Vaxcyte, Inc. — Director's Dealing 2021

Apr 8, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vaxcyte, Inc. (PCVX)
CIK: 0001649094
Period of Report: 2021-04-05

Reporting Person: Sauer Paul (SVP Process Dev, Manufacturing)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-05	Common Stock	J	38308	$0.00	Disposed	39591	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-05	Stock Option (right to buy)	$0.80	J	4168	Disposed	2026-04-19	Common Stock (4168)	Direct
2021-04-05	Stock Option (right to buy)	$1.79	J	14253	Disposed	2027-05-17	Common Stock (14253)	Direct
2021-04-05	Stock Option (right to buy)	$2.03	J	21871	Disposed	2028-07-23	Common Stock (21871)	Direct
2021-04-05	Stock Option (right to buy)	$2.03	J	7611	Disposed	2029-03-20	Common Stock (7611)	Direct

Footnotes

F1: Transfer of shares and the reporting person's economic interest in stock options (right to buy) to reporting person's spouse pursuant to a property settlement agreement in connection with separation proceedings. While the reporting person will retain the options, the reporting person's spouse will receive the economic benefit from, and has sole discretion with respect to, the portion of the options representing the spouse's transferred economic interest, including exercises thereof and sales of shares underlying such portion. Accordingly, the reporting person will not report beneficial ownership of or dispositions of the portion of such options representing the spouse's transferred economic interest, nor will the reporting person report beneficial ownership of or acquisitions or dispositions of the underlying shares, in future Section 16(a) filings.

F2: The shares subject to the option representing the reporting person's remaining economic interest are fully vested and exercisable.

F3: As of the date of transfer, the shares subject to the option representing the reporting person's remaining economic interest will vest in monthly installments with respect to 1,459 shares from April 24, 2021 to July 24, 2022.

F4: As of the date of transfer, the shares subject to the option representing the reporting person's remaining economic interest will vest in monthly installments with respect to 617 shares from May 1, 2021 to January 1, 2023.